Related Experiment Video
Updated: Oct 10, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
[Undesirable drug interactions of hypolipemic drugs]
1Zakładu Farmakologii Klinicznej IMW WAM w łodz.
Abstract:
The paper presents undesirable hypolipaemic drug interactions. Statins interactions are mainly connected with their hepatic metabolism by cytochrome P-450 isoenzymes. Most statins are metabolised by the CYP3A4 izoenzyme (lovastatin, simvastatin, atorvastatin, cerivastatin). The CYP3A4 isoenzyme is also responsible for the metabolism of wide range of drugs. The use of the combination of statins and some other drugs metabolised by, or affecting the activity of this same enzyme, may increase the risk of myopathy and rhabdomyolysis. It has been emphasized that pravastatin--and fluvastatin interactions are rarer and weaker than interactions of other statins. The most common appearance of interactions of hypolipaemic drugs, also other than statins have been presented.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Pharmacokinetics: Drug–Drug Interactions
Drug toxicity: Drug–Drug Interaction
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are typically...
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
